Quidel Corporation 代理


Quidel Corporation 代理

简要描述:Quidel Corporation代理,Quidel Corporation上海代理,Quidel Corporation北京代理, Quidel Corporation代理, Quidel Corporation一级代理, Quidel Corporation 代理
上海金畔生物科技有限公司 Quidel Corporation专业代理,具体产品信息欢迎电询:021-50837765

详细介绍

产品咨询

世界*实验材料供应商 Quidel Corporation 上海金畔生物为其中国代理, Quidel Corporation 在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品,的服务, Quidel Corporation 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

 Quidel Corporation 中国代理, Quidel Corporation 上海代理, Quidel Corporation 北京代理,Quidel Corporation 广东代理, Quidel Corporation 江苏代理Quidel Corporation 湖北代理,Quidel Corporation 天津,Quidel Corporation 黑龙江代理,Quidel Corporation 内蒙古代理,Quidel Corporation 吉林代理,Quidel Corporation 福建代理, Quidel Corporation 江苏代理, Quidel Corporation 浙江代理, Quidel Corporation 四川代理,

 

公司:www.quidel.com/

 

美国quidel公司是一个上市公司,本着提高人类健康和幸福的目标,在各地开拓、销售快速检测诊断试剂的企业,致力于研发产品,领域涉及妊娠、传染病、肿瘤、自身免疫性疾病和骨质疏松症

 

Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system.

Quidel commenced operations in 1979 and launched its first products in 1984. Since that time, Quidel has expanded its product base through internal development and acquisition with a focus on increasing its research and development efforts to accelerate the rate of new product introductions. Our core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development, and molecular assay development. Our current products fall generally into these categories: (1) lateral flow, where we are market leaders in infectious disease and reproductive health; (2) direct fluorescent antibodies (DFA), with expertise in infectious disease and virology; (3) micro-titer production, with a focus on bone and complement pathway markets; (4) fluorescent immunoassay products (Sofia); and (5) molecular diagnostic products including the world’s first FDA-cleared handheld molecular device, AmpliVue. Additional molecular and Sofia tests are currently in development or in clinical trials as part of a robust product pipeline.

Whether at our headquarters in San Diego, California, at our research and manufacturing operations in Ohio, Massachusetts, or in Germany, or through our Commercial organization around the world, Quidel is delivering a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare.

 

 

上海金畔生物科技有限公司